Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human Coagulation Factor VIII in Hemophilia A
CTR20171602Phase 3Completed
- Sponsor
- Nanyue Biopharmaceutical
- Start
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of antihemophilic factor human in hemophilia A, sponsored by Nanyue Biopharmaceutical. Started Dec 2017; status: completed.
02
Drugs
antihemophilic factor human
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20171602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171602.